1. Home
  2. PHR vs ARQT Comparison

PHR vs ARQT Comparison

Compare PHR & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHR
  • ARQT
  • Stock Information
  • Founded
  • PHR 2005
  • ARQT 2016
  • Country
  • PHR United States
  • ARQT United States
  • Employees
  • PHR N/A
  • ARQT N/A
  • Industry
  • PHR Business Services
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PHR Consumer Discretionary
  • ARQT Health Care
  • Exchange
  • PHR Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • PHR 1.5B
  • ARQT 1.7B
  • IPO Year
  • PHR 2019
  • ARQT 2020
  • Fundamental
  • Price
  • PHR $31.99
  • ARQT $15.65
  • Analyst Decision
  • PHR Strong Buy
  • ARQT Strong Buy
  • Analyst Count
  • PHR 14
  • ARQT 7
  • Target Price
  • PHR $32.07
  • ARQT $19.00
  • AVG Volume (30 Days)
  • PHR 686.3K
  • ARQT 1.8M
  • Earning Date
  • PHR 09-04-2025
  • ARQT 08-06-2025
  • Dividend Yield
  • PHR N/A
  • ARQT N/A
  • EPS Growth
  • PHR N/A
  • ARQT N/A
  • EPS
  • PHR N/A
  • ARQT N/A
  • Revenue
  • PHR $434,532,000.00
  • ARQT $263,464,999.00
  • Revenue This Year
  • PHR $14.74
  • ARQT $72.46
  • Revenue Next Year
  • PHR $11.57
  • ARQT $32.00
  • P/E Ratio
  • PHR N/A
  • ARQT N/A
  • Revenue Growth
  • PHR 16.29
  • ARQT 99.50
  • 52 Week Low
  • PHR $17.07
  • ARQT $8.03
  • 52 Week High
  • PHR $32.11
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • PHR 72.03
  • ARQT 53.12
  • Support Level
  • PHR $27.00
  • ARQT $13.70
  • Resistance Level
  • PHR $29.45
  • ARQT $16.27
  • Average True Range (ATR)
  • PHR 1.17
  • ARQT 0.74
  • MACD
  • PHR 0.39
  • ARQT -0.01
  • Stochastic Oscillator
  • PHR 97.50
  • ARQT 54.38

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: